Skip to Content

E5254 E5254 (Phendimetrazine Tartrate Extended-Release 105 mg)

Pill with imprint E5254 E5254 is Brown & Clear, Capsule-shape and has been identified as Phendimetrazine Tartrate Extended-Release 105 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Phendimetrazine is used in the treatment of obesity and belongs to the drug classes anorexiants, CNS stimulants. Risk cannot be ruled out during pregnancy. Phendimetrazine 105 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for E5254 E5254

Phendimetrazine tartrate extended-release 105 mg E5254 E5254
Phendimetrazine tartrate extended-release 105 mg E5254 E5254 Front
Phendimetrazine tartrate extended-release 105 mg E5254 E5254 Back
Phendimetrazine tartrate extended-release 105 mg E5254 E5254

Phendimetrazine Tartrate Extended-Release

Imprint
E5254 E5254
Strength
105 mg
Color
Brown & Clear
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Anorexiants, CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Sandoz Pharmaceuticals Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00185-5254 Eon Labs Inc.
49999-0360 Lake Erie Medical and Surgical Supply (repackager)
54569-2198 A-S Medication Solutions, LLC (repackager)
54868-3071 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "E5254 E5254"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.